Author
Dario Zoppi
Recent research
- Health & MedicineOpen access
BACKGROUND: Risdiplam improves motor function in spinal muscular atrophy (SMA), especially in children. In adults, subtle changes may not be captured by standard motor scales. OBJECTIVE: To describe 24-month motor outcomes, perceived global change, and safety of risdiplam in adul...
- BiologyOpen access
Background: Facioscapulohumeral muscular dystrophy (FSHD) is a progressive and heterogeneous disorder lacking reliable circulating biomarkers for disease monitoring and therapeutic response. We hypothesized that metabolic dysregulation, lipotoxicity, and endoplasmic reticulum (ER...